Redeye retains its positive view on Lagercrantz following a solid Q3 report with 10% organic growth and healthy margins. Following the solid development in the report, with outstanding cash flows and good M&A opportunities ahead we are making slight upward revisions to our forecasts.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.

Attachments

Lagercrantz - Cash Machine

© Modular Finance, source Nordic Press Releases